Ambien (Photo: Business Wire)
A seamless transition ensures continued supply for patients who rely on Ambien®
The acquisition builds on Cosette’s leading expertise in acquiring critical medicines from global pharmaceutical companies.
BRIDGEWATER, NJ, July 10, 2024–(COMMERCIAL CABLE)–Cosette Pharmaceuticals, Inc. (“Cosette”), a U.S.-based specialty pharmaceutical company, has completed the acquisition of Ambien® and Ambien CR® in the United States from Sanofi US.
“We are very pleased with the addition of Ambien to our portfolio,” said Apurva Saraf, President and CEO of Cosette. “We continue to leverage our proven, best-in-class capabilities to execute complex divestitures and integrate diverse products. This acquisition not only strengthens our product portfolio, but also reaffirms our commitment to ensuring that high-quality products continue to be available to patients around the world.”
According to IQVIA®, annual U.S. sales of Ambien® and Ambien® CR for the 12 months ending April 2024 were $39 million.
Cosette has a track record of successfully acquiring or divesting and integrating products from companies in Japan, Europe and the United States. Our strategic approach and deep industry expertise help us ensure seamless product divestments and transitions, ensuring uninterrupted access to critical medicines for millions of patients.
Patients and providers can learn more about Ambien® and Ambien CR®, including important safety information, at www.ambien.com
About Cosette Pharmaceuticals:
Cosette Pharmaceuticals, Inc. (“Cosette”) is a fully integrated, U.S.-based pharmaceutical company with a rapidly growing portfolio of branded pharmaceutical products including women’s health, cardiology and dermatology products. Cosette has a long history of manufacturing quality complex dosage forms such as topical creams, ointments, oral liquids/solutions and suppositories. Cosette has corporate and manufacturing facilities in New Jersey and North Carolina and is supported by over 300 dedicated employees across all functional areas. Cosette is backed by Avista Capital Partners, a private equity firm focused on the healthcare sector.
Visit www.cosettepharma.com and follow us on LinkedIn.
The original version of this release was posted on businesswire.com: https://www.businesswire.com/news/home/20240710788038/en/
Contacts
Business Development: bd@cosettepharma.com
Commercial: sales@cosettepharma.com
JOBs Apply News
For the Latest JOBs Apply News, Follow ©JOBs Apply News on Twitter and Linkedin Page.